Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Bgf Ukef 3 Nominees Limited (A/C Bgf Uk Enterprise Fund 3 Lp) investment portfolio
Bgf Ukef 3 Nominees Limited (A/C Bgf Uk Enterprise Fund 3 Lp) has made numerous investments in companies such as Purecyber, Dunad Therapeutics, and Proventeq Holdings within the Software & IT sector.
vc
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Dunad Therapeutics Ltd. Dunad Therapeutics is a transatlantic biopharmaceutical company that develops next‑generation, AI‑driven targeted protein‑degradation therapies. Its platform is partnered with major pharma such as Novartis to deliver transformative medicines for patients with unmet medical needs. | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-04-01 |
| Proventeq Holdings Limited | — | Reading | Confirmed | 2026-08-14 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
3 more similar investors hiddenSign up to unlock →
Shareholding changes (1)
Sign up free to see when this investor has bought or sold shares.
Sign up free